http://www.acc.org/Feed?clinicalTopicID=f24e6d2b-ba21-4c56-871d-d44e86eba30b Clinical Topic Feed: Cardiac Surgery and VHD en /Latest-in-Cardiology/Articles/2023/05/30/10/47/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Unrepaired-and-Repaired-Ventricular-Septal-Defects Ventricular septal defects (VSDs) are the most common form of congenital heart disease (CHD) diagnosed in childhood. There is a wide variation in clinical practice for the management of common types of VSDs. 1787745480000 Articles and Stories /Latest-in-Cardiology/Articles/2022/03/08/19/34/Clinical-Practice-Algorithm-For-the-Follow-up-of-Unrepaired-and-Repaired-SASD There is lack of evidence-based guidelines to help cardiologists determine the frequency of follow-up and testing in children with congenital heart disease (CHD). Thus, there remains a wide variation in clinical practice even for the management of common types of CHD. 1787745120000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/08/03/10/06/PARTNER-3 Both TAVR and SAVR were associated with a sustained, substantial improvement in patient-reported health status among patients with severe aortic stenosis (AS) considered at low risk, according to the seven-year outcomes of the PARTNER 3 trial published July 29 in JACC. 1785862800000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/28/17/19/Indexing-Ascending-Aortic-Dimensions Indexing ascending aortopathy (AA) to height better identifies patients, especially women, who could benefit from earlier surgery rather than absolute diameters, according to a recent study published in JACC: Advances. 1785325260000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/15/17/40/ACC-SCAI-and-STS-Submit-Feedback-on-Proposed-TAVR-NCD The ACC, along with the Society for Cardiovascular Angiography & Interventions (SCAI) and the Society of Thoracic Surgeons (STS), submitted formal comments to the Centers for Medicare and Medicaid Services (CMS) on July 15 regarding the proposed decision memo for the National Coverage Determination (NCD) for TAVR. 1784138100000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/12/47/eagles-eye-view-01jul2026 In this week’s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM). 1782910140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/PARTNER-3 TAVR and surgery demonstrated comparable and sustained valve durability in low-risk patients with symptomatic severe aortic stenosis (AS), with both approaches showing low and similar rates of structural valve deterioration (SVD), all-cause bioprosthetic valve failure (BVF) and reintervention through seven years... 1782845400000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/PARTNER-2A-P2S3i-Registry The rates of mortality and reintervention at 10 years were higher in patients at intermediate risk who underwent TAVR with the second-generation SAPIEN XT valve than those who underwent surgery in the PARTNER 2A trial, according to an analysis published June 16 in a valvular heart disease focus issue of JACC. 1782399420000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/17/17/38/CMS-Proposes-Updates-to-TAVR-National-Coverage-Determination The Centers for Medicare and Medicaid Services (CMS) released a proposed decision memo on the National Coverage Determination (NCD) for TAVR, introducing changes to coverage pathways, evidence development and quality oversight. 1781718060000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Feature-Navigating-Valve-Disease Shared decision-making has become central to the management of valve disease, including tricuspid regurgitation (TR) (see cover story) and severe aortic stenosis (AS). If done correctly, it can help clinicians engage patients and families in meaningful discussions about symptoms, prognosis, treatment burden and personal goals... 1780316280000 Articles and Stories